News
Rheumatoid arthritis and lung disease in the spotlight at #ACR20
Rheumatoid arthritis (RA) has long been established to have pulmonary manifestations such as interstitial lung disease (ILD), and several research groups are pursuing this respiratory burden of RA at #ACR20.
The Vaccine Review Process and why you should know it
There is much controversy regarding vaccine safety and efficacy in the United States. Prior to COVID19, there were populations who lacked confidence in vaccination for any number of reasons. Dr.
COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and rheumatic disease patients.
Rheumnow Podcast - ACR 2020 Retrospective (11.13.20)
Dr. Jack Cush reviews this past week at Virtual ACR 2020 - highlights from the meeting and his view of best/newest studies. What will people remember or talk about from ACR 2020?
ACR20 - Day 5.1 & 5.2 Podcasts
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Listen here:
ACR20 - Day 4 Report
Here are my highlights from day four, Monday, of the ACR 2020 Convergence.
Vaccine Immunogenicity with Tofacitinib
Erosions on X-ray: can we delegate this to the computers?
The prospect of automating hand x-ray scoring reliably has always been an enticing one, and data presented at the American College of Rheumatology (ACR) Convergence 2020 suggest this might be in reach in the near future – opening up the prospect of automatic x-ray scoring
Tofacitinib for Ankylosing Spondylitis
Investigations on the efficacy and safety of JAK inhibitors as a therapeutic option in the management of AS are increasing.
Ten-Year Analysis of Low-Dose Glucocorticoids in early RA
Abstract #1998 by C. Roubille et al from Montpellier, France is a 10-year prospective analysis that looked at the risk of severe outcomes related to very low-dose glucocorticoid in early rheumatoid arthritis from the ESPOIR cohort.
ACR20 - Day 5 Podcast
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Listen here:
